200959 |
GAMMA-AMINOBUTYRIC ACID TYPE A RECEPTOR RHO3 SUBUNIT (GENE/PSEUDOGENE) |
GABRR3 |
17969 |
ENSG00000183185 |
OTTHUMG00000159135 |
A8MPY1 |
GBRR3_HUMAN |
GABRQ |
GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT RHO-3 |
gamma-aminobutyric acid type A receptor subunit rho3 |
618668 |
Target Subclass | Ligand_gated_ion_channels |
Target Subclass | cys-loop |
Target Main Class | Receptors |
Transmembrane Helix Count | 4 |
Target Subclass | Channels |
Target Class | Receptors |
Target Subclass | TC:1.A.9 |
Interpro Acc | IPR006202 |
Human Readable Name | DRUGGABLE GENOME |
Interpro Type | Family |
Interpro Name | Neurotransmitter-gated ion-channel ligand-binding |
Interpro Type | Domain |
Interpro Acc | IPR006201 |
Interpro Short Name | Neur_channel |
Interpro Short Name | Neur_chan_lig-bd |
Uniprot Status | Swiss-Prot |
Interpro Name | Neurotransmitter-gated ion-channel |
Human Readable Name | ION CHANNEL |
Uniprot Evidence | 2: Evidence at transcript level |
Gene Biotype | PROTEIN_CODING |
ION CHANNEL |
DRUGGABLE GENOME |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | diazepam rectal gel |
Novel drug target | Established target |
Trial Name | NRL-01 |
potentiator |
Trial Name | ARX-03, sufentanil + triazolam NanoTab |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
n/a |
Trial Name | - |
Novel drug target | Established target |
n/a |
Trial Name | - |
Novel drug target | Established target |
n/a |
Novel drug target | Established target |
Trial Name | Clobazam |
n/a |
Novel drug target | Established target |
Trial Name | - |
n/a |
Trial Name | JZP-8 |
Novel drug target | Established target |
n/a |
Trial Name | alprazolam,Xanax, Xanax XR |
Novel drug target | Established target |
Trial Name | AZ-002, Staccato alprazolam |
n/a |
Trial Name | CNS-7056 |
Novel drug target | Established target |
n/a |
Trial Name | ocinaplon |
Novel drug target | Established target |
n/a |
Trial Name | NG2-73 |
Novel drug target | Established target |
GABRR3 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
GBRR3_HUMAN | Uniprot Id |
200959 | Entrez Gene Id |
A8MPY1 | Uniprot Accession |
Target Subclass | Ligand_gated_ion_channels |
Target Subclass | cys-loop |
Target Main Class | Receptors |
200959 | Entrez Gene Id |
GBRR3_HUMAN | Uniprot Id |
A8MPY1 | Uniprot Accession |
Interpro Acc | IPR006202 |
Human Readable Name | DRUGGABLE GENOME |
Interpro Type | Family |
ION CHANNEL, DRUGGABLE GENOME |
GABRR3 | Gene Symbol |
GABRQ | Gene Symbol |
Target Class | Receptors |
Target Subclass | TC:1.A.9 |
ENSG00000183185 | Gene Symbol |
GABRR3 | Ensembl Id |
DRUGGABLE GENOME |
Gamma-aminobutyric acid receptor subunit rho-3 | Gene Name |
A8MPY1 | UniProt ID |
ION CHANNEL |